mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |